About Martin Heidecker
Form D filings for Elion Therapeutics in 2024 list Martin Heidecker as director.
Martin Heidecker first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Martin Heidecker in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Martin Heidecker works with at each company, as listed on that company's latest Form D.
Elion Therapeutics, Inc. · Form D, Jun 26, 2024
